Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-M Riedinger

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bulletin Du Cancer|October 1, 1996
[Feasability of the dose adjustment of continuous infusion administration over 120 hours of 5-fluorouracil associated with cisplatin]B Coudert, C De Gislain, J L Beltramo, et al.
Bulletin Du Cancer|November 21, 2000
[Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group]J P Basuyau, M P Blanc-Vincent, J M Bidart, et al.
Annales De Biologie Clinique|April 9, 2002
[Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]J M Riedinger, N Eche, J P Basuyau, et al.
Bulletin Du Cancer|October 2, 2001
[Standards, options and recommendations for blood tumor markers in thyroid cancers]M F Pichon, J P Basuyau, G Gory-Delabaere, et al.
British Journal of Cancer|August 14, 2003
Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000J P Basuyau, M P Blanc-Vincent, J M Bidart, et al.
Bulletin Du Cancer|January 17, 2002
[Standards, options and recommendations for tumor markers in colorectal cancer]N Eche, M F Pichon, V Quillien, et al.
Neuroscience|April 24, 2012
Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteinsM Baarine, P Andréoletti, A Athias, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bulletin Du Cancer|October 1, 1996
[Feasability of the dose adjustment of continuous infusion administration over 120 hours of 5-fluorouracil associated with cisplatin]B Coudert, C De Gislain, J L Beltramo, et al.
Bulletin Du Cancer|November 21, 2000
[Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group]J P Basuyau, M P Blanc-Vincent, J M Bidart, et al.
Annales De Biologie Clinique|April 9, 2002
[Interpretation of the CA125 kinetics during first line chemotherapy of the ovarian cancer: methodological aspects and characteristic profiles]J M Riedinger, N Eche, J P Basuyau, et al.
Bulletin Du Cancer|October 2, 2001
[Standards, options and recommendations for blood tumor markers in thyroid cancers]M F Pichon, J P Basuyau, G Gory-Delabaere, et al.
British Journal of Cancer|August 14, 2003
Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000J P Basuyau, M P Blanc-Vincent, J M Bidart, et al.
Bulletin Du Cancer|January 17, 2002
[Standards, options and recommendations for tumor markers in colorectal cancer]N Eche, M F Pichon, V Quillien, et al.
Neuroscience|April 24, 2012
Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteinsM Baarine, P Andréoletti, A Athias, et al.
Pageof 3